Evidence against PALB2 involvement in Icelandic breast cancer susceptibility

[1]  W. Foulkes,et al.  Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women , 2007, Breast Cancer Research.

[2]  Olufunmilayo I. Olopade,et al.  Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations , 2007, Nature Reviews Cancer.

[3]  Petra M. Nederlof,et al.  Analysis of PALB2/FANCN-associated breast cancer families , 2007, Proceedings of the National Academy of Sciences.

[4]  Katri Pylkäs,et al.  A recurrent mutation in PALB2 in Finnish cancer families , 2007, Nature.

[5]  Hans Joenje,et al.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2 , 2007, Nature Genetics.

[6]  C. Mathew,et al.  Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer , 2007, Nature Genetics.

[7]  S. Seal,et al.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene , 2007, Nature Genetics.

[8]  F. Couch,et al.  Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. , 2006, Molecular cell.

[9]  J. Kere,et al.  Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families , 2001, European Journal of Human Genetics.

[10]  K. Stefánsson,et al.  mtDna and the islands of the North Atlantic: estimating the proportions of Norse and Gaelic ancestry. , 2001, American journal of human genetics.

[11]  Jaana M. Hartikainen,et al.  Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland , 2000, European Journal of Human Genetics.

[12]  K. Stefánsson,et al.  Estimating Scandinavian and Gaelic ancestry in the male settlers of Iceland. , 2000, American journal of human genetics.

[13]  A. Jonasdottir,et al.  A population study of mutations and LOH at breast cancer gene loci in tumours from sister pairs: two recurrent mutations seem to account for all BRCA1/BRCA2 linked breast cancer in Iceland. , 1998, Journal of medical genetics.

[14]  D. Easton,et al.  High prevalence of the 999del5 mutation in icelandic breast and ovarian cancer patients. , 1996, Cancer research.

[15]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.

[16]  N Risch,et al.  Genetic analysis of breast cancer in the cancer and steroid hormone study. , 1991, American journal of human genetics.

[17]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[18]  Nazneen Rahman,et al.  The emerging landscape of breast cancer susceptibility , 2007, Nature Genetics.

[19]  D. Easton,et al.  Genetic Linkage Analysis in Familial Breast and Ovarian Cancer: Results from 214 Families , 2006 .

[20]  A. Jonasdottir,et al.  Identification of a novel splice‐site mutation of the BRCA1 gene in two breast cancer families: Screening reveals low frequency in Icelandic breast cancer patients , 1998, Human mutation.

[21]  Tara L. Naylor,et al.  Distinct Genomic Profiles in Hereditary Breast Tumors Identified by Array-based Comparative Genomic Hybridization , 2022 .